These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1363 related items for PubMed ID: 27868281
1. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Stefanidis G, Viazis N, Kotsikoros N, Tsoukalas N, Lala E, Theocharis L, Fassaris A, Manolakopoulos S. Dis Esophagus; 2017 Feb 01; 30(3):1-8. PubMed ID: 27868281 [Abstract] [Full Text] [Related]
2. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Witteman BP, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, Stassen LP, Bouvy ND. Am J Gastroenterol; 2015 Apr 01; 110(4):531-42. PubMed ID: 25823768 [Abstract] [Full Text] [Related]
3. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, Heise JA, Turgeon DG, Fox MA. Surg Innov; 2015 Feb 01; 22(1):26-40. PubMed ID: 24756976 [Abstract] [Full Text] [Related]
4. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication. Bell RC, Mavrelis PG, Barnes WE, Dargis D, Carter BJ, Hoddinott KM, Sewell RW, Trad KS, DaCosta Gill B, Ihde GM. J Am Coll Surg; 2012 Dec 01; 215(6):794-809. PubMed ID: 22939637 [Abstract] [Full Text] [Related]
10. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Muls V, Eckardt AJ, Marchese M, Bastens B, Buset M, Devière J, Louis H, Rajan A, Daniel MA, Costamagna G. Surg Innov; 2013 Aug 01; 20(4):321-30. PubMed ID: 22968006 [Abstract] [Full Text] [Related]
13. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis. Richter JE, Kumar A, Lipka S, Miladinovic B, Velanovich V. Gastroenterology; 2018 Apr 01; 154(5):1298-1308.e7. PubMed ID: 29305934 [Abstract] [Full Text] [Related]
16. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. Cadière GB, Buset M, Muls V, Rajan A, Rösch T, Eckardt AJ, Weerts J, Bastens B, Costamagna G, Marchese M, Louis H, Mana F, Sermon F, Gawlicka AK, Daniel MA, Devière J. World J Surg; 2008 Aug 01; 32(8):1676-88. PubMed ID: 18443855 [Abstract] [Full Text] [Related]
17. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective. Trad KS, Barnes WE, Prevou ER, Simoni G, Steffen JA, Shughoury AB, Raza M, Heise JA, Fox MA, Mavrelis PG. Surg Innov; 2018 Apr 01; 25(2):149-157. PubMed ID: 29405886 [Abstract] [Full Text] [Related]
18. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients. Testoni PA, Corsetti M, Di Pietro S, Castellaneta AG, Vailati C, Masci E, Passaretti S. World J Surg; 2010 Apr 01; 34(4):750-7. PubMed ID: 20091308 [Abstract] [Full Text] [Related]